Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 3

Behavior and neuropsychiatric manifestations in Angelman syndrome

Authors Karine Pelc, Guy Cheron, Bernard Dan

Published 6 June 2008 Volume 2008:4(3) Pages 577—584

DOI https://dx.doi.org/10.2147/NDT.S2749

Karine Pelc1, Guy Cheron2, Bernard Dan1,2

1Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium; 2Laboratory of Neurophysiology and Movement Biomechanics, Université Libre de Bruxelles (ULB), Brussels, Belgium

Abstract: Angelman syndrome has been suggested as a disease model of neurogenetic developmental condition with a specific behavioral phenotype. It is due to lack of expression of the UBE3A gene, an imprinted gene located on chromosome 15q. Here we review the main features of this phenotype, characterized by happy demeanor with prominent smiling, poorly specific laughing and general exuberance, associated with hypermotor behavior, stereotypies, and reduced behavioral adaptive skills despite proactive social contact. All these phenotypic characteristics are currently difficult to quantify and have been subject to some differences in interpretation. For example, prevalence of autistic disorder is still debated. Many of these features may occur in other syndromic or nonsyndromic forms of severe intellectual disability, but their combination, with particularly prominent laughter and smiling may be specific of Angelman syndrome. Management of problematic behaviors is primarily based on behavioral approaches, though psychoactive medication (eg, neuroleptics or antidepressants) may be required.

Keywords: Angelman syndrome, UBE3A, chromosome 15, behavioral phenotypes, autism, neurogenetics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysis

Ma SC, Zhao Y, Zhang T, Ling XL, Zhao D

OncoTargets and Therapy 2015, 8:641-648

Published Date: 16 March 2015

Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition

Zaccaria A, Roux-Dalvai F, Bouamrani A, Mombrun A, Mossuz P, Monsarrat B, Berger F

International Journal of Nanomedicine 2015, 10:1869-1883

Published Date: 9 March 2015

Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomes

Perez AP, Casasco A, Schilrreff P, Defain Tesoriero MV, Duempelmann L, Altube MJ, Higa L, Morilla MJ, Petray P, Romero EL

International Journal of Nanomedicine 2014, 9:3335-3345

Published Date: 10 July 2014

A preliminary report of the dopamine receptor D4 and the dopamine transporter 1 gene polymorphism and its association with attention deficit hyperactivity disorder

Helmut Niederhofer, Frauke Menzel, Karl Göbel, Brigitte Hackenberg, Rainer Richter, et al

Neuropsychiatric Disease and Treatment 2008, 4:701-705

Published Date: 8 August 2008

Magnetic nanoparticles for gene and drug delivery

Stuart C McBain, Humphrey HP Yiu, Jon Dobson

International Journal of Nanomedicine 2008, 3:169-180

Published Date: 6 June 2008

Noninvasive assessment of preclinical atherosclerosis

Helen A Lane, Jamie C Smith, J Stephen Davies

Vascular Health and Risk Management 2006, 2:19-30

Published Date: 15 March 2006

Marked effect of milnacipran combined with olanzapine for a delusional depressive patient

Yuka Sugawara, Hisashi Higuchi, Keizo Yoshida, Tetsuo Shimizu

Neuropsychiatric Disease and Treatment 2005, 1:373-374

Published Date: 15 December 2005

Genetic and molecular aspects of spinocerebellar ataxias

Viktor Honti, László Vécsei

Neuropsychiatric Disease and Treatment 2005, 1:125-133

Published Date: 15 July 2005